Back to search

Poland· PL-100043555

Metronidazol 0,5% Polpharma

A metronidazole product containing metronidazolum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 12 of our 19 countries.

ATC J01XD01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMetronidazol 0,5% PolpharmaATCJ01XD01REGISTER NO.PL-100043555PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Metronidazole is registered in 12 of 19 countries.

Countries holding a registration under ATC J01XD01 (metronidazole), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Metronidazole · ATC J01XD01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Metronidazolum
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Country
Poland (PL)
ATC code
J01XD01
ATC class
Metronidazole
Defined daily dose
1.5 g, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990160419
  • gtin
    05909990160426
  • gtin
    05909990160433
  • gtin
    05909991429058

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

752 interactions on record for metronidazole.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Metronidazole · interactions on record

752 records

  • 10 severe
  • 143 moderate
  • 223 minor
  • 376 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • EthanolB05XX04severe
  • AmprenavirJ05AE05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6aeaae6e-3d8d-4c04-8155-90875d50dc39
GET /v1/drugs/6aeaae6e-3d8d-4c04-8155-90875d50dc39?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań i infuzji",
  "source": "urpl",
  "strength": "5 mg/ml",
  "packaging": "05909990160419 ¦ Lz ¦ Skasowane ¦ 6514\n5 amp. 20 ml\n05909990160426 ¦ Lz ¦ 6515\n10 amp. 20 ml\n05909990160433 ¦ Lz ¦ 6516\n1 poj. 100 ml\n05909991429058 ¦ Lz ¦ 136227\n40 poj. 100 ml",
  "substance": "Metronidazolum 100 mg",
  "common_name": "Metronidazolum",
  "pl_product_id": "100043555",
  "pozwolenie_nr": "01604",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about metronidazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.